Outset Medical, Inc. financial data

Symbol
OM on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
3052 Orchard Drive, San Jose, CA
State of incorporation
DE
Former names
Home Dialysis Plus, Ltd. (to 2/25/2011)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 619 % -6.03%
Quick Ratio 119 % +22.7%
Debt-to-equity 281 % +269%
Return On Equity -170 % -92.4%
Return On Assets -44.5 % +11.1%
Operating Margin -112 % +14%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.5M shares +4.66%
Common Stock, Shares, Outstanding 52.5M shares +4.71%
Entity Public Float 1.1B USD +55.1%
Common Stock, Value, Issued 52K USD +4%
Weighted Average Number of Shares Outstanding, Basic 50.5K shares +1.18%
Weighted Average Number of Shares Outstanding, Diluted 50.5K shares +1.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 115M USD -13%
Research and Development Expense 43M USD -23.4%
Selling and Marketing Expense 76.8M USD -21.4%
General and Administrative Expense 44.6M USD -0.77%
Operating Income (Loss) -129M USD +25.2%
Nonoperating Income (Expense) 10M USD +2.08%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -140M USD +19.9%
Income Tax Expense (Benefit) 607K USD +27.8%
Net Income (Loss) Attributable to Parent -141M USD +19.8%
Earnings Per Share, Basic -2.74 USD/shares +23%
Earnings Per Share, Diluted -2.74 USD/shares +23%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33.3M USD -8.29%
Cash, Cash Equivalents, and Short-term Investments 194M USD -14.7%
Accounts Receivable, after Allowance for Credit Loss, Current 34.3M USD -3.48%
Inventory, Net 61.4M USD +27.3%
Assets, Current 275M USD -3%
Property, Plant and Equipment, Net 9.49M USD -31.1%
Operating Lease, Right-of-Use Asset 4.31M USD -24.5%
Other Assets, Noncurrent 484K USD -49.6%
Assets 293M USD -4.77%
Accounts Payable, Current 4.3M USD +49.1%
Contract with Customer, Liability, Current 12.8M USD +17.9%
Liabilities, Current 42.4M USD -20%
Contract with Customer, Liability, Noncurrent 77K USD -22.2%
Operating Lease, Liability, Noncurrent 3.16M USD -35.6%
Liabilities 245M USD +57.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 352K USD
Retained Earnings (Accumulated Deficit) -1.06B USD -15.3%
Stockholders' Equity Attributable to Parent 47.8M USD -68.6%
Liabilities and Equity 293M USD -4.77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -45.9M USD -2.58%
Net Cash Provided by (Used in) Financing Activities 68.6M USD +1200%
Net Cash Provided by (Used in) Investing Activities -59M USD -2333%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 52.5M shares +4.71%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -36.3M USD +1.37%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 36.6M USD -7.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.92M USD +98.6%
Deferred Tax Assets, Valuation Allowance 222M USD +20.5%
Deferred Tax Assets, Gross 223M USD +20.2%
Operating Lease, Liability 6.08M USD -11.9%
Payments to Acquire Property, Plant, and Equipment 354K USD -56.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -140M USD +19.8%
Lessee, Operating Lease, Liability, to be Paid 7.01M USD -15.1%
Property, Plant and Equipment, Gross 29.6M USD +11.1%
Operating Lease, Liability, Current 1.75M USD +13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.11M USD +10.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.05M USD +10.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 934K USD -31.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.95M USD -0.86%
Deferred Tax Assets, Operating Loss Carryforwards 161M USD +22.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.78M USD +24.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.46M USD +5.49%
Deferred Tax Assets, Net of Valuation Allowance 1.34M USD -11.8%
Share-based Payment Arrangement, Expense 33.5M USD -9.16%
Interest Expense 21.5M USD +89%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%